Leptomeningeal Metastasis

Restricted access

Article Information

© AANS, except where prohibited by US copyright law.

References

  • 1.

    Balm MHammack J: Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 53:6266321996Balm M Hammack J: Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 53:626–632 1996

    • Search Google Scholar
    • Export Citation
  • 2.

    Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. J Neurooncol 23:2332381995Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. J Neurooncol 23:233–238 1995

    • Search Google Scholar
    • Export Citation
  • 3.

    Chamberlain MC: New approaches to and current treatments of leptomeningeal metastases. Curr Opin Neurol 7:4925001994Chamberlain MC: New approaches to and current treatments of leptomeningeal metastases. Curr Opin Neurol 7:492–500 1994

    • Search Google Scholar
    • Export Citation
  • 4.

    Chamberlain MCDirr L: Involved-field radiotherapy and intraommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 11:197819931993Chamberlain MC Dirr L: Involved-field radiotherapy and intraommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 11:1978–1993 1993

    • Search Google Scholar
    • Export Citation
  • 5.

    Chamberlain MCKormanik P: Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol (In press 1997)Chamberlain MC Kormanik P: Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol (In press 1997)

    • Search Google Scholar
    • Export Citation
  • 6.

    Chamberlain MCKormanik P: Leptomeningeal metastases due to melanoma: combined modality therapy. Int J Oncol 9:5055101996Chamberlain MC Kormanik P: Leptomeningeal metastases due to melanoma: combined modality therapy. Int J Oncol 9:505–510 1996

    • Search Google Scholar
    • Export Citation
  • 7.

    Chamberlain MCKormanik PA: Prognostic significance of 111Indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 46:167416771996Chamberlain MC Kormanik PA: Prognostic significance of 111Indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 46:1674–1677 1996

    • Search Google Scholar
    • Export Citation
  • 8.

    Freilich RJKrol GDeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51571995Freilich RJ Krol G DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51–57 1995

    • Search Google Scholar
    • Export Citation
  • 9.

    Glass JPMelamed MChernik NLet al: Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:136913751979Glass JP Melamed M Chernik NL et al: Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375 1979

    • Search Google Scholar
    • Export Citation
  • 10.

    Grossman SAMoynihan TJ: Neoplastic meningitis. Neurol Clin 9:8348561991Grossman SA Moynihan TJ: Neoplastic meningitis. Neurol Clin 9:834–856 1991

    • Search Google Scholar
    • Export Citation
  • 11.

    Siegal TLossos APfeffer MR: Leptomeningeal metastasis: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 44:146314691994Siegal T Lossos A Pfeffer MR: Leptomeningeal metastasis: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 44:1463–1469 1994

    • Search Google Scholar
    • Export Citation

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 181 181 25
Full Text Views 59 59 0
PDF Downloads 47 47 0
EPUB Downloads 0 0 0

PubMed

Google Scholar